STAT

JANUARY 13, 2025

Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project , a database of genetic data that is expected to accelerate personalized medicine and help discover new drugs. 

Medical Records 313

Medical Records Pharmaceutical Companies Pharmaceutical Companies Drug Development 313

STAT

NOVEMBER 7, 2022

More than two dozen institutions have been contacted as of this week, according to the Clinical Trials Registration and Results Reporting Taskforce, a national consortium of academic medical centers, universities, hospitals, and nonprofit organizations focused on clinical trial transparency. Continue to STAT+ to read the full story…

Hospitals 245

Hospitals Drug Development 245

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

STAT

APRIL 3, 2023

When the long-awaited moment arrived, a nurse helped Adam Hess loosen a tiny plastic clamp on an intravenous line leading to the chest of his son, who lay asleep in a bed at Boston Children’s Hospital. They had been modified in a lab by adding a functional gene to compensate for a defective one.

Hospitals 231

Hospitals Drug Pricing Drug Development 231

STAT

NOVEMBER 30, 2022

The scientists sent the blood 950 miles east to Massachusetts General Hospital in Boston, to a tiny lab (recently converted from a storeroom) where a 28-year-old postdoc named James Gusella and his 23-year-old research technician, Rudolph Tanzi, got to work.

Hospitals 255

Hospitals Drug Development 255

pharmaphorum

FEBRUARY 10, 2021

The consortium behind the scheme consists of 17 different organisations from member states in total, including seven universities and four research hospitals, plus input from the Sano Foundation international research foundation, the non-government organisation the VPH Institute. Deutsches Institut fu?r

Drug Development 76

Drug Development Packaging Documentation Hospitals 76

STAT

SEPTEMBER 30, 2024

Health Resources and Services Administration sent a  final warning letter  to Johnson & Johnson urging the company to inform the agency by today that it would halt its plan to alter payment methods for some hospitals that participate in the 340B drug discount program. J&J

Hospitals 191

Hospitals Drug Development 191

Express Pharma

JUNE 28, 2024

Orchid Pharma, announced the launch of its new drug – Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.

Hospitals 94

Hospitals Drug Development 94

STAT

MARCH 31, 2025

This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday.    Sign up here.    Boy, last week was a doozy. More government layoffs, a national security leak, and everyone’s mad about The Bachelor’s pick. Let’s catch you up.

Drug Development 152

Drug Development Hospitals 152

Pharmacy Is Right For Me

APRIL 4, 2023

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! In this position, she works with patients in the comfort of their homes after being discharged from a hospital setting. Please describe your novel practice setting.

Hospitals 130

Hospitals Communication Medical Records Dosage 130

Express Pharma

OCTOBER 20, 2023

Program partners with government hospitals to strengthen drug development in the country Roche Pharma India has announced the launch of its clinical trial excellence project in India with an objective to strengthen the capabilities of public health institutions to do clinical trials and drug research in the country.

Hospitals 98

Hospitals Drug Development 98

pharmaphorum

AUGUST 19, 2022

Since DiMe’s launch in October 2019, there has been a 929% increase in the number of digital endpoints being used by the life sciences industry for the safety and efficacy of new drug development. The post Fuelling the efficiency of drug development through sensor data integration appeared first on.

Drug Development 52

Drug Development Documentation Hospitals 52

STAT

OCTOBER 10, 2024

Amid excitement over everything from Chat-GPT to Nobel Prize-winning chemistry research that uses artificial intelligence to predict protein structures, academics Aravind Narayan and Sayash Kapoor have established a reputation for throwing cold water on at least some of the claims about how AI will transform people’s lives. 

Drug Development 331

Drug Development Hospitals 331

Pharmacy Times

JANUARY 2, 2024

Billions of samples are discarded while investigators struggle to assemble collections.

Drug Development 40

Drug Development Hospitals 40

Pharmaceutical Technology

JULY 21, 2022

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. 3D bioprinting offers an alternative to animal testing in drug development. Data are collected from each stage and then analysed by AI algorithms to increase efficiency and productivity. 3D printing.

Drug Development 98

Drug Development Hospitals 98

Outsourcing Pharma

AUGUST 31, 2020

The US institute has given a new contract to drug developer BioCryst to explore use of galidesivir in treatment of non-hospitalized COVID-19 patients.

Hospitals 52

Hospitals Drug Development 52

Express Pharma

SEPTEMBER 25, 2023

Dr Peder M Andersen, CEO of Biosergen, said, “Alkem has capabilities and a strong track record in drug development. Sandeep Singh, Alkem’s MD, said, “This is a strategic fit for Alkem’s portfolio given our presence in acute care segment, especially in hospital-based treatment.”

Hospitals 102

Hospitals Drug Development 102

pharmaphorum

APRIL 1, 2021

We speak to the company’s CEO and co-founder, Szabolcs Nagy, to find out why moving beyond traditional biotech drug development is a good fit for the country’s ecosystem. It’s incredibly exciting to see what can be done with the right data and digital expertise combined with experienced drug developers. COVID impacts.

Drug Development 123

Drug Development Hospitals 123

STAT

SEPTEMBER 30, 2024

How much health care’s bigwigs are making Mike Reddy for STAT Health care stocks lagged behind the broader market in 2023, and that was reflected in many CEO pay packages. My colleagues and I completed our annual tradition of analyzing CEO compensation. For 2023, we input data for 313 health care CEOs and found they made $3.5

Packaging 237

Packaging Drug Development Hospitals 237

European Pharmaceutical Review

JANUARY 4, 2024

Prophylactic treatment as a preventative measure The new study, published in Blood Cancer Discovery , stated that in the future, this could eliminate the need to administer teclistamab and other immunotherapies in hospitals. “In We are going with full steam into an era of immunotherapy.”

Immunity 97

Immunity Immunization Hospitals Drug Development 97

European Pharmaceutical Review

AUGUST 7, 2023

Continuous-flow manufacturing could help smaller communities and hospitals manufacture essential drugs such as antibiotics , as needed, the paper noted. By adopting this method, we believe that we can contribute to a stable drug supply, respond to rare diseases and disasters, and aid new drug development.”

Compounding 97

Compounding Hospitals Drug Development 97

pharmaphorum

DECEMBER 15, 2021

It is drug developers, patients, advocates, and caregivers in active conversations—more likely to involve clean sheets of paper than prepared scripts. The goal must be to reference what has been learned at every stage of the drug-development pipeline—so that patient insights become guiding principles rather than afterthoughts.

Drug Development 145

Drug Development Communication Hospitals 145

European Pharmaceutical Review

JULY 7, 2022

Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceutical companies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. . Dr Hughes earned his MD and PhD at Yale School of Medicine.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

pharmaphorum

NOVEMBER 11, 2022

Pick the brains of 140+ senior level drug developers across industry and academia at the physical return of the only meeting dedicated to overcoming challenges in biomarker understanding, disease selection and clinical translation in inflammasome-centered drug development.

Medical Schools 52

Medical Schools Immunity Immunization Hospitals 52

STAT

FEBRUARY 21, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at the legacy of a pharma CEO, yet more biotech layoffs, and a reprieve from the GLP-1 panic. Read the rest…

Drug Pricing 237

Drug Pricing Drug Development Hospitals 237

STAT

DECEMBER 13, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning.

Drug Development 229

Drug Development Hospitals 229

Express Pharma

JULY 17, 2024

In addition, they also allow precise targeting of disease mechanisms, reducing the overall cost associated with drug development which means faster access to effective treatments for neurological disorders to patients not only in India but worldwide. Both of them and Dr Michael P.

Medical Schools 105

Medical Schools Compounding Hospitals Drug Development 105

European Pharmaceutical Review

AUGUST 31, 2023

Hospital staff must also be protected from radiation while handling the agent. Thus, hospitals must isolate treated patients and implement consistent patient waste management procedures (eg, collecting all patient excreta). To address these challenges, radiopharmaceutical companies have developed a variety of approaches.

Hospitals 97

Hospitals Drug Development Chemotherapy 97

STAT

DECEMBER 6, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Today Megan Molteni tells us how infertility worries will likely temper sickle cell patients’ embrace of new gene therapies. Read the rest…

Drug Development 220

Drug Development Hospitals 220

European Pharmaceutical Review

AUGUST 25, 2022

In the CAPELLA study, lenacapavir, in combination with other antiretroviral therapies, demonstrated sustained rates of virologic suppression and clinically meaningful CD4+ T-cell recovery in people with multi-drug resistant HIV. There is currently no cure for HIV or AIDS.

Hospitals 102

Hospitals Drug Development 102

pharmaphorum

NOVEMBER 24, 2022

Despite significant advances in treatment in recent years, those living with the condition on average spend several weeks in hospital each year, receiving emergency treatment. Travel to hospital for regular check-ups is frequently needed. Meanwhile, in the UK alone there are over 10,000 people living with cystic fibrosis (CF).

Hospitals 59

Hospitals Compounding Drug Development 59

pharmaphorum

JUNE 24, 2022

Fujifilm’s Irvine Scientific unit has licensed rights to an artificial intelligence-powered technology developed to improve the success rate of in vitro fertilisation (IVF) techniques. “Development and testing of applications to support the selection of oocytes, sperm, and genetic assessment are in progress,” he added.

Hospitals 52

Hospitals Drug Development 52

Definitive Healthcare

FEBRUARY 23, 2024

Resource Type E-Books & How-To Guides Blog How-To Guide Healthcare Insight Medical claims 101: What you need to know How to sell effectively to healthcare facilities and executives using the right… Hospital payor mix by state Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToS

Drug Pricing 52

Drug Pricing Hospitals Drug Development 52

FDA Law Blog: Biosimilars

OCTOBER 10, 2023

She completed her residency and a fellowship in medical oncology/hematology at Brown University, Roger Williams Medical Center, and Brown University Affiliated Hospitals. We are thrilled that she is joining the firm and will add her expertise to our already exceptional Drug Development Team,” said JP Ellison, HP&M’s Managing Director.

Drug Development 49

Drug Development Hospitals 49

pharmaphorum

MAY 19, 2021

In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19. . The FDA begs to differ, saying: “the data from CD12 illustrated imbalances in mortality among subgroups, some favouring leronlimab and some favouring placebo.”

Hospitals 64

Hospitals Drug Development 64

European Pharmaceutical Review

OCTOBER 23, 2024

In July, Chilamula Srija, Pharma Analyst at GlobalData, remarked that donanemab’s monthly dosing regimen reduces hospital visits “by half, presenting a potential advantage in patient convenience”. Donanemab was approved by the US Food and Drug Administration (FDA) as Kisunla (donanemab-azbt) in July 2024.

Hospitals 52

Hospitals Drug Development 52

pharmaphorum

NOVEMBER 28, 2022

Substra is the software that powered the MELLODDY platform, a collaboration in which Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis, and Servier all agreed to share drug discovery data — but not with each other directly, nor with Owkin.

Hospitals 72

Hospitals Drug Development 72